Focus Therapy Areas: Oncology, Haematology, Neuroimmunology, Cardiovascular
Specialist Expertise: Cell & Gene Therapy, Rare Diseases, Digital Health
Education: BSc Biotechnology with a Year in Research, Imperial College London (First Class); MPhil Bioscience Enterprise University of Cambridge
What is your focus at Eradigm?
My focus is delivering high impact strategic insights at brand-level through peri-launch and post-launch Competitive Intelligence work, which includes attendance to leading therapy area conferences. My primary objective is providing value to the client with a meaningful so what? to ensure our contribution truly serves to identify future directions and tangible next steps.
Who do you work with?
My clients mainly include global CI managers, global and affiliate brand teams as well as senior strategic leaders across the top 15 biopharmaceuticals companies. On several occasions, my work has also exposed me to senior executive members from those organisations.
What is your specialist expertise, and what types of projects do you work on?
During my time at Eradigm, I have specialised in understanding the scientific and commercial value of cell & gene therapy (autologous, allogeneic), digital healthcare (digital therapeutics, screening algorithms) and rare neuroimmunological diseases. Within these fields, I have worked in CI monitoring projects, global technology landscaping and strategic workshop facilitation.
What did you do before Eradigm?
Before joining Eradigm, I interned in the Business Development Operations division at AstraZeneca, where I researched the regulatory and pricing interdependencies between European and International markets.
What are your passions outside of work?
I am deeply curious about pretty much everything that happens around me, be it international politics, pop Instagram culture or a new restaurant that just opened down the road. However, my favourite ways of tetrising my free time include urban exploration, dinner hosting, swimming and 70s Italian thriller movies.